Corvus Pharmaceuticals
CRVS
CRVS
92 hedge funds and large institutions have $167M invested in Corvus Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 32 increasing their positions, 9 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
6% more funds holding
Funds holding: 87 → 92 (+5)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
30% less call options, than puts
Call options by funds: $702K | Put options by funds: $1.01M
Holders
92
Holding in Top 10
2
Calls
$702K
Puts
$1.01M
Top Buyers
| 1 | +$17M | |
| 2 | +$12.7M | |
| 3 | +$5.75M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.15M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$3.09M |
Top Sellers
| 1 | -$12.9M | |
| 2 | -$5.21M | |
| 3 | -$3.53M | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$1.62M |
| 5 |
Jane Street
New York
|
-$991K |
